Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Clinical Therapeutics features a special report in its April issue focusing primarily on the behavioral issues associated with patients' self-management of type 2 diabetes. "Diabetes, perhaps more so than any other chronic disease, requires people to significantly modify their behaviors—sometimes in ways that are contrary to their cultural norms and backgrounds—even when they don't 'feel' sick or experience symptoms of the disease," said John G. Ryan, Dr.PH., Topic Editor for Endocrinology and Diabetes, and guest editor for the April 2014 Diabetes Update, entitled Race, Risk and Behaviors. Publication of the Diabetes Update coincided with the recent approval from the US Food and Drug Administration of a new dapagliflozin from AstraZeneca and Bristol-Myers Squibb for the treatment of adults with type 2 diabetes.
Type 2 diabetes is a metabolic disorder affecting about 24 million people in the United States. An asymptomatic period that occurs between the onset of diabetic hyperglycemia, the elevated blood sugar levels that are a hallmark sign of type 2 diabetes, and clinical diagnosis is estimated to last from four to seven years, and many people are estimated to have had the condition for an average of ten years prior to diagnosis and treatment.
http://phys.org/wire-news/160219996/race-risk-and-behaviors-a-type-2-diabetes-update.html
It's interesting that US health insurance companies seem to recognise the importance of testing in order to manage Type 2, probably because they know that it will potentially save bigger costs in the future. Clearly, there is a problem still with educating patients, however.
Type 2 diabetes is a metabolic disorder affecting about 24 million people in the United States. An asymptomatic period that occurs between the onset of diabetic hyperglycemia, the elevated blood sugar levels that are a hallmark sign of type 2 diabetes, and clinical diagnosis is estimated to last from four to seven years, and many people are estimated to have had the condition for an average of ten years prior to diagnosis and treatment.
http://phys.org/wire-news/160219996/race-risk-and-behaviors-a-type-2-diabetes-update.html
It's interesting that US health insurance companies seem to recognise the importance of testing in order to manage Type 2, probably because they know that it will potentially save bigger costs in the future. Clearly, there is a problem still with educating patients, however.
Last edited: